Listed

Bolt Biotherapeutics, Inc.

BOLTNasdaqCIK 1641281HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$5.0k, Q2 FY2026
Operating income−$8.4m, Q2 FY2026
Net income−$7.7m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m2.5Revenue, Q3 FY2023, three months to 2023-09-30$2.5m. XBRL concept us-gaap:Revenues. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure2.1Revenue, Q4 FY2023, three months to 2023-12-31$2.1m. XBRL concept us-gaap:Revenues. 10-K filed 2025-03-24, accession 0000950170-25-043873. Derived: 12-month figure less the 9-month figure.Report this figure5.3Revenue, Q1 FY2024, three months to 2024-03-31$5.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure1.3Revenue, Q2 FY2024, three months to 2024-06-30$1.3m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure1.1Revenue, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure0.0Revenue, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure1.2Revenue, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure1.8Revenue, Q2 FY2025, three months to 2025-06-30$1.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure2.2Revenue, Q3 FY2025, three months to 2025-09-30$2.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure2.5Revenue, Q4 FY2025, three months to 2025-12-31$2.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure0.0Revenue, Q1 FY2026, three months to 2026-03-31$26.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure0.0Revenue, Q2 FY2026, three months to 2026-06-30$5.0k. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Research and development$m15.0Research and development, Q3 FY2023, three months to 2023-09-30$15.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure16.3Research and development, Q4 FY2023, three months to 2023-12-31$16.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-24, accession 0000950170-25-043873. Derived: 12-month figure less the 9-month figure.Report this figure16.5Research and development, Q1 FY2024, three months to 2024-03-31$16.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure15.4Research and development, Q2 FY2024, three months to 2024-06-30$15.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure13.8Research and development, Q3 FY2024, three months to 2024-09-30$13.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure11.7Research and development, Q4 FY2024, three months to 2024-12-31$11.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure9.5Research and development, Q1 FY2025, three months to 2025-03-31$9.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure7.5Research and development, Q2 FY2025, three months to 2025-06-30$7.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure6.5Research and development, Q3 FY2025, three months to 2025-09-30$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure5.0Research and development, Q4 FY2025, three months to 2025-12-31$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure4.8Research and development, Q1 FY2026, three months to 2026-03-31$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure5.1Research and development, Q2 FY2026, three months to 2026-06-30$5.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Operating income$m(18.2)Operating income, Q3 FY2023, three months to 2023-09-30−$18.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure(19.8)Operating income, Q4 FY2023, three months to 2023-12-31−$19.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043873. Derived: 12-month figure less the 9-month figure.Report this figure(17.1)Operating income, Q1 FY2024, three months to 2024-03-31−$17.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure(22.6)Operating income, Q2 FY2024, three months to 2024-06-30−$22.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure(16.4)Operating income, Q3 FY2024, three months to 2024-09-30−$16.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure(16.9)Operating income, Q4 FY2024, three months to 2024-12-31−$16.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure(12.1)Operating income, Q1 FY2025, three months to 2025-03-31−$12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(9.2)Operating income, Q2 FY2025, three months to 2025-06-30−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure(7.7)Operating income, Q3 FY2025, three months to 2025-09-30−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure(7.1)Operating income, Q4 FY2025, three months to 2025-12-31−$7.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure(7.6)Operating income, Q1 FY2026, three months to 2026-03-31−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(8.4)Operating income, Q2 FY2026, three months to 2026-06-30−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Net income$m(16.3)Net income, Q3 FY2023, three months to 2023-09-30−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure(17.9)Net income, Q4 FY2023, three months to 2023-12-31−$17.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-24, accession 0000950170-25-043873. Derived: 12-month figure less the 9-month figure.Report this figure(10.8)Net income, Q1 FY2024, three months to 2024-03-31−$10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure(21.2)Net income, Q2 FY2024, three months to 2024-06-30−$21.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure(15.2)Net income, Q3 FY2024, three months to 2024-09-30−$15.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure(15.9)Net income, Q4 FY2024, three months to 2024-12-31−$15.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure(11.0)Net income, Q1 FY2025, three months to 2025-03-31−$11.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(8.6)Net income, Q2 FY2025, three months to 2025-06-30−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure(7.1)Net income, Q3 FY2025, three months to 2025-09-30−$7.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure(6.6)Net income, Q4 FY2025, three months to 2025-12-31−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure(7.2)Net income, Q1 FY2026, three months to 2026-03-31−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(7.7)Net income, Q2 FY2026, three months to 2026-06-30−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Diluted EPS$ per share(0.43)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure(11.12)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$11.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure(7.93)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$7.93 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figurenot reported(5.76)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$5.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(4.46)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$4.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure(3.72)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$3.72 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figurenot reported(4.31)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$4.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(4.57)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$4.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Basic EPS$ per share(0.43)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figurenot reported(0.28)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure(11.12)Basic EPS, Q2 FY2024, three months to 2024-06-30−$11.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure(7.93)Basic EPS, Q3 FY2024, three months to 2024-09-30−$7.93 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figurenot reported(5.76)Basic EPS, Q1 FY2025, three months to 2025-03-31−$5.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(4.46)Basic EPS, Q2 FY2025, three months to 2025-06-30−$4.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure(3.72)Basic EPS, Q3 FY2025, three months to 2025-09-30−$3.72 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figurenot reported(4.31)Basic EPS, Q1 FY2026, three months to 2026-03-31−$4.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(4.57)Basic EPS, Q2 FY2026, three months to 2026-06-30−$4.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure

Balance sheet

Cash and equivalents$12.9m, Q2 FY2026
Shareholders' equity$12.6m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m9.2Cash and equivalents, Q3 FY2023, at 2023-09-30$9.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure10.8Cash and equivalents, FY2023, at 2023-12-31$10.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-24, accession 0000950170-25-043873.Report this figure4.3Cash and equivalents, Q1 FY2024, at 2024-03-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure6.2Cash and equivalents, Q2 FY2024, at 2024-06-30$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure9.4Cash and equivalents, Q3 FY2024, at 2024-09-30$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure7.2Cash and equivalents, FY2024, at 2024-12-31$7.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-12, accession 0001193125-26-104121.Report this figure8.4Cash and equivalents, Q1 FY2025, at 2025-03-31$8.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure9.6Cash and equivalents, Q2 FY2025, at 2025-06-30$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure17.8Cash and equivalents, Q3 FY2025, at 2025-09-30$17.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure11.7Cash and equivalents, FY2025, at 2025-12-31$11.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure11.6Cash and equivalents, Q1 FY2026, at 2026-03-31$11.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure12.9Cash and equivalents, Q2 FY2026, at 2026-06-30$12.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Current assets$m125Current assets, Q3 FY2023, at 2023-09-30$125.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062048.Report this figure106Current assets, FY2023, at 2023-12-31$105.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043873.Report this figure95.1Current assets, Q1 FY2024, at 2024-03-31$95.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059564.Report this figure76.6Current assets, Q2 FY2024, at 2024-06-30$76.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096200.Report this figure57.1Current assets, Q3 FY2024, at 2024-09-30$57.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure50.8Current assets, FY2024, at 2024-12-31$50.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104121.Report this figure42.5Current assets, Q1 FY2025, at 2025-03-31$42.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure38.3Current assets, Q2 FY2025, at 2025-06-30$38.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure35.6Current assets, Q3 FY2025, at 2025-09-30$35.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure30.3Current assets, FY2025, at 2025-12-31$30.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure25.8Current assets, Q1 FY2026, at 2026-03-31$25.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure20.6Current assets, Q2 FY2026, at 2026-06-30$20.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Total assets$m175Total assets, Q3 FY2023, at 2023-09-30$175.4m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062048.Report this figure160Total assets, FY2023, at 2023-12-31$159.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-24, accession 0000950170-25-043873.Report this figure143Total assets, Q1 FY2024, at 2024-03-31$142.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059564.Report this figure124Total assets, Q2 FY2024, at 2024-06-30$124.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096200.Report this figure109Total assets, Q3 FY2024, at 2024-09-30$109.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure99.6Total assets, FY2024, at 2024-12-31$99.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-12, accession 0001193125-26-104121.Report this figure85.9Total assets, Q1 FY2025, at 2025-03-31$85.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure75.5Total assets, Q2 FY2025, at 2025-06-30$75.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure65.1Total assets, Q3 FY2025, at 2025-09-30$65.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure56.7Total assets, FY2025, at 2025-12-31$56.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure48.0Total assets, Q1 FY2026, at 2026-03-31$48.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure40.3Total assets, Q2 FY2026, at 2026-06-30$40.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Current liabilities$m18.8Current liabilities, Q3 FY2023, at 2023-09-30$18.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062048.Report this figure20.5Current liabilities, FY2023, at 2023-12-31$20.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-24, accession 0000950170-25-043873.Report this figure16.7Current liabilities, Q1 FY2024, at 2024-03-31$16.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059564.Report this figure17.9Current liabilities, Q2 FY2024, at 2024-06-30$17.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096200.Report this figure18.1Current liabilities, Q3 FY2024, at 2024-09-30$18.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure15.9Current liabilities, FY2024, at 2024-12-31$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-12, accession 0001193125-26-104121.Report this figure13.6Current liabilities, Q1 FY2025, at 2025-03-31$13.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure12.3Current liabilities, Q2 FY2025, at 2025-06-30$12.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure10.0Current liabilities, Q3 FY2025, at 2025-09-30$10.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure8.4Current liabilities, FY2025, at 2025-12-31$8.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure7.3Current liabilities, Q1 FY2026, at 2026-03-31$7.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure7.9Current liabilities, Q2 FY2026, at 2026-06-30$7.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Total liabilities$m47.1Total liabilities, Q3 FY2023, at 2023-09-30$47.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062048.Report this figure47.0Total liabilities, FY2023, at 2023-12-31$47.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-24, accession 0000950170-25-043873.Report this figure38.7Total liabilities, Q1 FY2024, at 2024-03-31$38.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059564.Report this figure38.3Total liabilities, Q2 FY2024, at 2024-06-30$38.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096200.Report this figure37.3Total liabilities, Q3 FY2024, at 2024-09-30$37.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure42.4Total liabilities, FY2024, at 2024-12-31$42.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-12, accession 0001193125-26-104121.Report this figure39.1Total liabilities, Q1 FY2025, at 2025-03-31$39.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure36.7Total liabilities, Q2 FY2025, at 2025-06-30$36.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure33.0Total liabilities, Q3 FY2025, at 2025-09-30$33.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure30.2Total liabilities, FY2025, at 2025-12-31$30.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure28.2Total liabilities, Q1 FY2026, at 2026-03-31$28.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure27.7Total liabilities, Q2 FY2026, at 2026-06-30$27.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure
Shareholders' equity$m128Shareholders' equity, Q3 FY2023, at 2023-09-30$128.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure113Shareholders' equity, FY2023, at 2023-12-31$112.7m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-12, accession 0001193125-26-104121.Report this figure104Shareholders' equity, Q1 FY2024, at 2024-03-31$104.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure85.9Shareholders' equity, Q2 FY2024, at 2024-06-30$85.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure72.0Shareholders' equity, Q3 FY2024, at 2024-09-30$72.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure57.2Shareholders' equity, FY2024, at 2024-12-31$57.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure46.8Shareholders' equity, Q1 FY2025, at 2025-03-31$46.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure38.8Shareholders' equity, Q2 FY2025, at 2025-06-30$38.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure32.1Shareholders' equity, Q3 FY2025, at 2025-09-30$32.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure26.5Shareholders' equity, FY2025, at 2025-12-31$26.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure19.8Shareholders' equity, Q1 FY2026, at 2026-03-31$19.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure12.6Shareholders' equity, Q2 FY2026, at 2026-06-30$12.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure

Cash flow

Operating cash flow−$6.5m, Q2 FY2026
Capital expenditure$0, Q4 FY2025
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(16.7)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$16.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-125413. Derived: 9-month figure less the 6-month figure.Report this figure(14.3)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-24, accession 0000950170-25-043873. Derived: 12-month figure less the 9-month figure.Report this figure(16.8)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$16.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure(16.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$16.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-14, accession 0001641281-25-000007. Derived: 6-month figure less the 3-month figure.Report this figure(14.0)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$14.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277549. Derived: 9-month figure less the 6-month figure.Report this figure(14.4)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$14.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure(13.4)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$13.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(9.6)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$9.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344597. Derived: 6-month figure less the 3-month figure.Report this figure(9.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$9.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277549. Derived: 9-month figure less the 6-month figure.Report this figure(7.2)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figure(8.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure(6.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344597. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$165.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-125413. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-24, accession 0000950170-25-043873. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-14, accession 0000950170-24-059564.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-08-13, accession 0000950170-24-096200. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$41.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-277549. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$72.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001193125-25-277549. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-12, accession 0001193125-26-104121. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)1.69m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares37.5Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3037,454,340 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062048.Report this figure37.7Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3137,684,023 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0000950170-24-059564.Report this figure37.8Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3037,750,393 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096200.Report this figure37.9Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3037,868,480 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0000950170-24-125413.Report this figure38.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3138,068,424 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0000950170-25-069188.Report this figure1.9Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,906,496 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-14, accession 0001641281-25-000007.Report this figure1.9Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,912,554 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure1.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,916,943 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure1.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,917,629 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure1.9Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,919,441 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277549.Report this figure1.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,680,445 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001193125-26-219382.Report this figure1.7Diluted shares (weighted), Q2 FY2026, three months to 2026-06-301,690,529 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure

Shares outstanding: 1.93mShares outstanding, period not labelled, at 2026-08-041,926,345 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344597.Report this figure at Aug 4, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.